Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Kerr Corporation — Predicate Candidate Screening
32 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
90 daysmedian FDA review time
163 days90th percentile
32clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K252890 | ZenSeal Pro | Kerr Corporation | 2026-01-07 | 118 | 0 |
| K222830 | Rainbow 360 | Kerr Corporation | 2023-01-12 | 115 | 0 |
| K221255 | SimpliShade Bulk Fill, SimpliShade Bulk Fill Flow | Kerr Corporation | 2022-08-31 | 121 | 0 |
| K191548 | Nexus Universal Self-Cure | Kerr Corporation | 2019-10-11 | 121 | 0 |
| K182162 | OptiBond eXTRa Universal | Kerr Corporation | 2018-11-07 | 89 | 0 |
| K162948 | Styptin, Hemogin-L, Hemodettes, and GingiGEL Aluminum Chlori | Kerr Corporation | 2017-08-08 | 291 | 0 |
| K163064 | Demi Ultra | Kerr Corporation | 2017-07-18 | 258 | 0 |
| K162536 | GingiKnit+, GingiBraid+, GingiBraid+ Shortcut, and UniBraid+ | Kerr Corporation | 2017-02-03 | 144 | 0 |
| K162164 | GingiKnit+, GingiBraid+, and Shortcut with GingiBraid+ Non-I | Kerr Corporation | 2017-01-13 | 163 | 0 |
| K162436 | EndoVac Pure | Kerr Corporation | 2016-12-21 | 112 | 0 |
| K162257 | P1145 Dental Restorative | Kerr Corporation | 2016-11-07 | 88 | 0 |
| K160441 | Identic and KromaFaze Alginate Dental Impression Materials | Kerr Corporation | 2016-06-30 | 134 | 0 |
| K123468 | DEMI ULTRA | Kerr Corporation | 2013-03-20 | 131 | 0 |
| K123595 | NEXUS RMGI | Kerr Corporation | 2013-02-19 | 90 | 0 |
| K110747 | TEMPFLEX | Kerr Corporation | 2011-06-14 | 89 | 0 |
| K110092 | TAKE 1 ADVANCED RIGID TRAY | Kerr Corporation | 2011-04-08 | 86 | 0 |
| K102621 | SOLSTICE | Kerr Corporation | 2011-01-28 | 137 | 0 |
| K103351 | DMC COMPOSITE 2 | Kerr Corporation | 2011-01-20 | 65 | 0 |
| K101756 | TSC | Kerr Corporation | 2010-10-26 | 125 | 0 |
| K102163 | REALSEAL XT SEALER | Kerr Corporation | 2010-10-16 | 75 | 0 |
| K102133 | GIRAFFE2 | Kerr Corporation | 2010-10-07 | 70 | 0 |
| K101423 | OPTIBOND XTR | Kerr Corporation | 2010-07-30 | 71 | 0 |
| K100347 | OPTIBOND SE | Kerr Corporation | 2010-04-30 | 77 | 0 |
| K100083 | ESTHETICA | Kerr Corporation | 2010-03-19 | 66 | 0 |
| K092176 | TAKE 1 ADVANCED RIGID TRAY | Kerr Corporation | 2010-01-28 | 191 | 0 |
| K093484 | PREMISE FLOWABLE MODIFIED | Kerr Corporation | 2010-01-27 | 79 | 0 |
| K091023 | METAMORPHOSIS | Kerr Corporation | 2009-05-21 | 41 | 0 |
| K073209 | MAXCEM 2 | Kerr Corporation | 2008-01-29 | 76 | 3 |
| K071429 | TI2200 TRANSILLUMINATION CABLE | Kerr Corporation | 2007-09-10 | 110 | 0 |
| K071251 | DEMI | Kerr Corporation | 2007-07-26 | 83 | 0 |
| K062519 | NEXUS 3 | Kerr Corporation | 2006-10-19 | 52 | 0 |
| K060472 | PREMISE FLOWABLE | Kerr Corporation | 2006-04-28 | 64 | 42 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda